Cardiac resynchronization therapy: Caveat medicus!MEHRA, Mandeep R; GREENBERG, Barry H.Journal of the American College of Cardiology. 2004, Vol 43, Num 7, pp 1145-1148, issn 0735-1097, 4 p.Article

Improving the titer of recombinant adenovirus by suppressing problematic transgene transcription during packagingXIAOWEI ZHANG; GREENBERG, Barry H; COWLING, Randy T et al.BioTechniques. 2008, Vol 44, Num 1, pp 85-89, issn 0736-6205, 5 p.Article

Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor α-converting enzymeIWATA, Michikado; SILVA ENCISO, Jorge E; GREENBERG, Barry H et al.American journal of physiology. Cell physiology. 2009, Vol 66, Num 5, issn 0363-6143, C1318-C1329Article

Highlights of the Year in JACC 2013DEMARIA, Anthony N; ADLER, Eric D; MAHMUD, Ehtisham et al.Journal of the American College of Cardiology. 2014, Vol 63, Num 6, pp 570-602, issn 0735-1097, 33 p.Article

Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial) : a placebo-controlled randomised trial. CommentarySLIWA, Karen; ANSARI, Aftab A; MOYE, Lemuel A et al.Lancet (British edition). 2008, Vol 371, Num 9608, issn 0140-6736, 184-186, 228-236 [12 p.]Article

Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure : A report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)GREENBERG, Barry H; ABRAHAM, William T; YOUNG, James B et al.The American heart journal. 2007, Vol 154, Num 4, pp 647-654, issn 0002-8703, 8 p.Article

Pharmacokinetic profile of controlled-release carvedilol in patients with left ventricular dysfunction associated with chronic heart failure or after myocardial infarctionPACKER, Milton; LUKAS, Mary Ann; TENERO, David M et al.The American journal of cardiology. 2006, Vol 98, Num 7, issn 0002-9149, 39L-45L, SUPArticle

Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodelingGURANTZ, Devorah; YNDESTAD, Arne; HALVORSEN, Bente et al.Cardiovascular research. 2005, Vol 67, Num 1, pp 106-115, issn 0008-6363, 10 p.Article

Pharmacokinetics and pharmacodynamics of rivaroxaban and its effect on biomarkers of hypercoagulability in patients with chronic heart failureGHEORGHIADE, Mihai; THYSSEN, An; ZOLYNAS, Robert et al.The Journal of heart and lung transplantation. 2011, Vol 30, Num 2, pp 218-226, issn 1053-2498, 9 p.Article

Influence of Beta-Blocker Continuation or Withdrawal on Outcomes in Patients Hospitalized With Heart Failure : Findings From the OPTIMIZE-HF ProgramFONAROW, Gregg C; ABRAHAM, William T; ALBERT, Nancy M et al.Journal of the American College of Cardiology. 2008, Vol 52, Num 3, pp 190-199, issn 0735-1097, 10 p.Article

Relation of Low Hemoglobin and Anemia to Morbidity and Mortality in Patients Hospitalized With Heart Failure (Insight from the OPTIMIZE-HF Registry)YOUNG, James B; ABRAHAM, William T; FONAROW, Gregg C et al.The American journal of cardiology. 2008, Vol 101, Num 2, pp 223-230, issn 0002-9149, 8 p.Article

Pharmacologic Therapies Across the Continuum of Left Ventricular DysfunctionABRAHAM, William T; GREENBERG, Barry H; YANCY, Clyde W et al.The American journal of cardiology. 2008, Vol 102, Num 5, issn 0002-9149, 21G-28G, SUPArticle

Acute hemodynamic and clinical effects of levosimendan in patients with severe Heart failureSLAWSKY, Mara T; COLUCCI, Wilson S; NICKLAS, John et al.Circulation (New York, N.Y.). 2000, Vol 102, Num 18, pp 2222-2227, issn 0009-7322Article

DEPRESSION RATINGS AND ANTIDEPRESSANT USE AMONG OUTPATIENT HEART FAILURE PATIENTS: IMPLICATIONS FOR THE SCREENING AND TREATMENT OF DEPRESSIONJIMENEZ, Jessica A; REDWINE, Laura L; RUTLEDGE, Thomas R et al.International journal of psychiatry in medicine. 2012, Vol 44, Num 4, pp 315-334, issn 0091-2174, 20 p.Article

Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: Findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)FLAHERTY, James D; ROSSI, Joseph S; YOUNG, James B et al.The American heart journal. 2009, Vol 157, Num 6, pp 1018-1025, issn 0002-8703, 8 p.Article

Association between performance measures and clinical outcomes for patients hospitalized with heart failureFONAROW, Gregg C; ABRAHAM, William T; YOUNG, James B et al.JAMA, the journal of the American Medical Association. 2007, Vol 297, Num 1, pp 61-70, issn 0098-7484, 10 p.Article

Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure : Results of the organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIXE-HF)FONAROW, Gregg C; ABRAHAM, William T; YOUNG, James B et al.Archives of internal medicine (1960). 2007, Vol 167, Num 14, pp 1493-1502, issn 0003-9926, 10 p.Article

Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failurePACKER, Milton; ABRAHAM, William T; PINA, Ileana L et al.Journal of the American College of Cardiology. 2006, Vol 47, Num 11, pp 2245-2252, issn 0735-1097, 8 p.Article

Effects of cytokine treatment on angiotensin II type 1A receptor transcription and splicing in rat cardiac fibroblastsCOWLING, Randy T; XIAOWEI ZHANG; REESE, Vanessa C et al.American journal of physiology. Heart and circulatory physiology. 2005, Vol 58, Num 3, pp H1176-H1183, issn 0363-6135Article

Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program: Correlation With OutcomesMETRA, Marco; COTTER, Gad; DOROBANTU, Maria I et al.Journal of the American College of Cardiology. 2013, Vol 61, Num 2, pp 196-206, issn 0735-1097, 11 p.Article

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trialTEERLINK, John R; COTTER, Gad; DOROBANTU, Maria I et al.Lancet (British edition). 2013, Vol 381, Num 9860, pp 29-39, issn 0140-6736, 11 p.Article

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trialCLELAND, John G. F; TEERLINK, John R; SHABURISHVILI, Tamaz et al.Lancet (British edition). 2011, Vol 378, Num 9792, pp 676-683, issn 0140-6736, 8 p.Article

Quality of Care of and Outcomes for African Americans Hospitalized With Heart Failure : Findings From the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) RegistryYANCY, Clyde W; ABRAHAM, William T; YOUNG, James B et al.Journal of the American College of Cardiology. 2008, Vol 51, Num 17, pp 1675-1684, issn 0735-1097, 10 p.Article

Risk Stratification and Prognostic Factors in the Post-Myocardial Infarction PatientCANNON, Christopher P; GREENBERG, Barry H.The American journal of cardiology. 2008, Vol 102, Num 5, issn 0002-9149, 13G-20G, SUPArticle

Depression in heart failure : A meta-analytic review of prevalence, intervention effects, and associations with clinical outcomesRUTLEDGE, Thomas; REIS, Veronica A; LINKE, Sarah E et al.Journal of the American College of Cardiology. 2006, Vol 48, Num 8, pp 1527-1537, issn 0735-1097, 11 p.Article